Triptorelin | CAS:57773-63-4

We serve Triptorelin CAS:57773-63-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Triptorelin

Chemical Name:Triptorelin
CAS.NO:57773-63-4
Synonyms:Triptorelin
triptorelinum
triptoreline
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Molecular Formula C64H82N18O13
Molecular Weight 1311.449
Index of Refraction 1.723
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Triptoreline as an antineoplastic (hormonal) is currently used in the treatment of prostatic cancer where therapy may be required over months or years. It is also used in the treatment of endometriosis and infertility.



Contact us for information like Triptorelin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,triptoreline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,triptoreline Use and application,Triptorelin technical grade,usp/ep/jp grade.


Related News: Although bird flu poses more of a danger to poultry than humans — it is not easily transmissible among people — the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic.3-Bromo-4-methyl-2-pyridinamine manufacturer Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media.2,3-Difluoropyridine supplier Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media.2-[(3-methyl-4-nitropyridin-2-yl)methylsulfanyl]-1H-benzimidazole vendor Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.Major global airports, including London Heathrow, are monitoring people arriving from China for signs of illness.